Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.15
Bid: 17.80
Ask: 18.50
Change: -0.30 (-1.63%)
Spread: 0.70 (3.933%)
Open: 18.45
High: 0.00
Low: 0.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of NGSoft

1 Mar 2021 07:00

RNS Number : 6021Q
BATM Advanced Communications Ld
01 March 2021
 

LEI: 213800FLQUB9J289RU66

1 March 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Update on Sale of NGSoft

 

Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021.

 

The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021.

 

NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEIFWAEFSEDE
Date   Source Headline
26th Nov 202012:21 pmRNSBlock Listing Interim Review
23rd Nov 202011:58 amRNSNotice of AGM
5th Oct 20207:00 amRNSMajor new customer for COVID-19 diagnostic tests
27th Aug 20207:00 amRNSBATM secures first tier 1 customer for NFVTime
17th Aug 20207:00 amRNSInterim Results
6th Aug 20206:16 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSNotice of Results
5th Aug 20208:09 amRNSSuccessful proof-of-concept with Vodafone
15th Jul 20207:00 amRNSBATM expands COVID-19 diagnostic tests
25th Jun 20207:00 amRNSBusiness and Trading Update
4th Jun 202012:01 pmRNSHolding(s) in Company
26th May 20207:00 amRNSBlock Listing Application
6th May 202011:45 amRNSHolding(s) in Company
5th May 20207:00 amRNSBATM Launches Antibody Tests for COVID-19
30th Apr 20204:33 pmRNSAnnual Financial Report - DTR 6.3.5 Disclosure
30th Apr 20207:00 amRNSCOVID-19 Update
22nd Apr 20207:00 amRNSBATM receives c. $31m order to produce ventilators
19th Mar 20207:00 amRNSNovamed partnership for COVID-19 diagnostics kit
6th Mar 20207:00 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSFull Year Results
27th Feb 20207:00 amRNSBATM Develops Diagnostics Kit for COVID-19
24th Feb 20207:00 amRNSAward of $4m follow-on cyber contract
12th Feb 20207:00 amRNSNotice of Results
10th Feb 20207:00 amRNSThird international agri-waste contract
7th Feb 20207:00 amRNSHolding(s) in Company
23rd Jan 202011:43 amRNSHolding(s) in Company
22nd Jan 20205:54 pmRNSHolding(s) in Company
7th Jan 20207:00 amRNSFirst commercial agreement for Ador
5th Dec 20193:49 pmRNSResult of AGM
5th Dec 20197:00 amRNS$4m agri-waste treatment contract in Taiwan
7th Nov 20197:00 amRNSNotice of AGM
8th Oct 20197:00 amRNSDirector Share Purchases
7th Oct 20197:00 amRNSExpansion of cyber offering and follow-on contract
2nd Oct 20197:00 amRNSBATM completes delivery under Arm agreement
10th Sep 20197:00 amRNSDirector Shareholding, Issue of Equity and TVR
2nd Sep 20192:19 pmRNSHolding(s) in Company
23rd Aug 20197:00 amRNSBATM joins Tel-Aviv Stock Exchange indices
20th Aug 20192:34 pmRNSHolding(s) in Company
19th Aug 20197:00 amRNSInterim Results
7th Aug 201911:11 amRNSShare Option Exercise, Issue of Equity and TVR
5th Aug 20197:00 amRNSNotice of Results
31st Jul 20192:45 pmRNSReceipt of c. $3.4m from sale of IBC holding
22nd Jul 20197:00 amRNSBATM Advances 5G Strategy with New T-Metro 8104
11th Jul 20199:20 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
11th Jul 20197:45 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
8th Jul 20197:00 amRNSSecondary Listing on the Tel Aviv Stock Exchange
25th Jun 20198:28 amRNSResults of Placing and Subscription
24th Jun 20195:26 pmRNSProposed Fundraise to raise a minimum of US$15m
17th Jun 20197:00 amRNSNew solution under NXP Semiconductors partnership
10th Jun 20197:00 amRNSBATM Cyber Security Partnership with Clavister

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.